Cargando…

Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system

BACKGROUND: To describe and analyze the patterns of adverse events associated with dipeptidyl peptidase-4 inhibitors (DPP-4is) (sitagliptin, saxagliptin, linagliptin, vildagliptin, and alogliptin) from the FDA Adverse Event Reporting System (FAERS) and to highlight areas of safety concerns. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jing, Jia, Yuntao, Sun, Shusen, Meng, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493367/
https://www.ncbi.nlm.nih.gov/pubmed/32938499
http://dx.doi.org/10.1186/s40360-020-00447-w